SCHEMBL29814701

SCHEMBL29814701

N[C@H](CCNS(=O)(=O)c1ccc([N+](=O)[O-])cc1)C(=O)O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC1A3 P43003 1/20 0.56
SLC1A2 P43004 1/20 0.56
SLC1A1 P43005 1/20 0.56
MEN1 O00255 5/20 0.53
KMT2A Q03164 5/20 0.53
ALDH1A1 P00352 4/20 0.53
CA1 P00915 4/20 0.53
CA2 P00918 4/20 0.53
PKM P14618 1/20 0.53
MAPT P10636 3/20 0.51
GAA P10253 2/20 0.50
KDM4E B2RXH2 1/20 0.50
LMNA P02545 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
GRM8 O00222 1/20 0.49
GRM6 O15303 1/20 0.49
GRM4 Q14833 1/20 0.49
RAB9A P51151 1/20 0.49
MMP1 P03956 2/20 0.49
MMP2 P08253 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29814907 1.00 SLC1A3 (0.56) SLC1A3SLC1A2SLC1A1MEN1KMT2A
SCHEMBL29814950 0.92 ALDH1A1 (0.55) SLC1A3SLC1A2SLC1A1MEN1KMT2A
SCHEMBL29814995 0.92 ALDH1A1 (0.55) SLC1A3SLC1A2SLC1A1MEN1KMT2A
SCHEMBL29557249 0.91 ALDH1A1 (0.54) SLC1A3SLC1A2SLC1A1MEN1KMT2A
SCHEMBL26641058 0.91 ALDH1A1 (0.54) SLC1A3SLC1A2SLC1A1MEN1KMT2A
SCHEMBL26641062 0.91 ALDH1A1 (0.54) SLC1A3SLC1A2SLC1A1MEN1KMT2A
SCHEMBL29814999 0.86 SLC1A3 (0.59) SLC1A3SLC1A2SLC1A1MEN1KMT2A
SCHEMBL29814857 0.86 SLC1A3 (0.59) SLC1A3SLC1A2SLC1A1MEN1KMT2A
SCHEMBL1768517 0.83 CA1 (0.63) SLC1A3SLC1A2SLC1A1MEN1KMT2A
SCHEMBL2234191 0.83 CA1 (0.63) SLC1A3SLC1A2SLC1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11395857-B2 Radiolabeled melanocortin 1 receptor-specific alpha-melanocyte-stimulating hormone analogues for imaging or therapy PROVINCIAL HEALTH SERVICES AUTHORITY (CA) 2022-07-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11395857-B2 Radiolabeled melanocortin 1 receptor-specific alpha-melanocyte-stimulating hormone analogues for imaging or therapy MC1R, MC5R, MC3R SLC1A3 400/4885SLC1A2 256/4885SLC1A1 322/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.